However, BCR-ABL rearranged pre-B-acute lymphoblastic leukemia (ALL) is driven by an aberrant expression of AID [47], which is expressed at such an early stage of B lymphocyte development [48], as a consequence of the enhanced kinase activity of BCR-ABL1 fusion protein (i.e., tyrosine kinase P210) [47,49]. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.